PRA issued a letter to chief risk officers of general insurance firms, setting out insights from its supervisory review work. The letter focuses on reserving and exposure management, including some observations on uncertainty in light of the COVID-19 crisis. PRA believes that the insights will be useful as firms prepare for the year-end reserving exercise and plan for the 2021 underwriting year. PRA expects the board and reserving committee to reflect the observations presented in this letter appropriately and explicitly as part of setting the year-end Solvency II and booked reserves.
In the letter, PRA highlights that two of the areas of concern—bias in reserve estimates and possible weakening in case reserve estimates—persist in the analysis of the latest Solvency II reporting as at year-end 2019. The analysis indicates that reserving assumptions may have weakened over time, while data show that the claims experience continues to deteriorate. The board is encouraged to satisfy itself that the key assumptions related to the rate of future claims development remain appropriate, that the case reserving has not weakened over time, and that there is no unjustified anchoring to optimistic business plan loss ratios. In addition, PRA notes that COVID-19 has given rise to additional complexity and uncertainty in estimating ultimate losses, which has been grouped into four key areas:
- Data—A number of firms have not been able to accurately identify and track COVID-19 exposed policies. Firms should ensure that this uncertainty is reflected in the reserve estimates and that, where possible, appropriate procedures are put in place to identify and track exposed policies.
- Discontinuities in historical trends—A number of firms’ estimates for COVID-19 losses on casualty classes may be optimistic. Consequently, PRA encourages firms to make sufficient allowance for the uncertainty related to both the direct impact of COVID losses as well as the indirect impacts on claims arising from the downturn in the wider economy.
- Appropriateness of common reserving methodologies—Given that the historical claims experience may not be a good guide for estimating future COVID-19 losses, alternative approaches such as the use of benchmarking and exposure-based analyses will be particularly useful to consider alongside more common reserving methodologies.
- Reinsurance adequacy—Where there is a material reliance on reinsurance to protect against losses, be it intragroup or third party, PRA encourages the board to satisfy itself that those arrangements are adequate. It would be prudent to stress-test the assumptions related to reinsurance recoveries to understand the impact of reinsurance not responding as expected, and then to ensure sufficient allowance is made for this uncertainty when setting reserves.
With respect to the exposure management frameworks across market, PRA has observed that the frameworks for non-property classes of business are less mature than for property classes. Another observation is that the state of man-made catastrophe risk assessment remains significantly behind that of the natural catastrophe risk assessment. Firms can expect PRA to increase its focus on firms that are materially exposed to man-made catastrophe risk and where progress toward better practice remains slow. In the letter, PRA is also encouraging firms to actively consider whether current risk and capital management frameworks—including current stress and scenario testing—sufficiently address the risks posed by contract uncertainty and unintended exposures. It may be useful to consider the identification, definition, and monitoring of all risk related to contract wording, including any key assumptions related to expected coverage. This includes the risk related to reinsurance contract wordings where coverage may not fully align with all assumed perils or events detailed in the underlying insurance contracts.
Related Link: Letter
Keywords: Europe, UK, Insurance, Reinsurance, COVID-19, Reserving, Exposure Management, Solvency II, Reporting, Benchmarking, Stress Testing, PRA
Previous ArticleFSB Report Examines Progress in Implementation of Regulatory Reforms
Next ArticleAPRA Consults on Revisions to Remuneration Standard
The Prudential Regulation Authority (PRA) published the final policy statement PS21/21 on the leverage ratio framework in the UK. PS21/21, which sets out the final policy of both the Financial Policy Committee (FPC) and PRA
The Consumer Financial Protection Bureau (CFPB) proposed to amend Regulation B to implement changes to the Equal Credit Opportunity Act (ECOA) under Section 1071 of the Dodd-Frank Act.
The Prudential Regulation Authority (PRA) decided to maintain, at the 2019 levels, the buffer rates for the Other Systemically Important Institutions (O-SII) for another year, with no new rates to be set until December 2023.
The Financial Stability Board (FSB) published a progress report on implementation of its high-level recommendations for the regulation, supervision, and oversight of global stablecoin arrangements.
In a letter to the authorized deposit taking institutions, the Australian Prudential Regulation Authority (APRA) announced an increase in the minimum interest rate buffer it expects banks to use when assessing the serviceability of home loan applications.
The Committee on Payments and Market Infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO) are consulting on the preliminary guidance that clarifies that stablecoin arrangements should observe international standards for payment, clearing, and settlement systems.
The European Banking Authority (EBA) and the European Insurance and Occupational Pensions Authority (EIOPA) have set out their respective work priorities for 2022.
The Malta Financial Services Authority (MFSA) updated the guidelines on supervisory reporting requirements under the reporting framework 3.0, in addition to the reporting module on leverage under the common reporting (COREP) framework.
The European Commission (EC) published the Implementing Decision 2021/1753 on the equivalence of supervisory and regulatory requirements of certain third countries and territories for the purposes of the treatment of exposures, in accordance with the Capital Requirements Regulation or CRR (575/2013).
EC published the Implementing Regulation 2021/1751, which lays down implementing technical standards on uniform formats and templates for notification of determination of the impracticability of including contractual recognition of write-down and conversion powers.